ID30448A - Sel induk hibrid manusia untuk mengekspresikan gen mamalia - Google Patents

Sel induk hibrid manusia untuk mengekspresikan gen mamalia

Info

Publication number
ID30448A
ID30448A IDW00200101235A ID20011235A ID30448A ID 30448 A ID30448 A ID 30448A ID W00200101235 A IDW00200101235 A ID W00200101235A ID 20011235 A ID20011235 A ID 20011235A ID 30448 A ID30448 A ID 30448A
Authority
ID
Indonesia
Prior art keywords
cells
human
recombinant
genes
expression
Prior art date
Application number
IDW00200101235A
Other languages
English (en)
Indonesian (id)
Inventor
Myung-Sam Cho
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ID30448A publication Critical patent/ID30448A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
IDW00200101235A 1998-12-10 1999-12-08 Sel induk hibrid manusia untuk mengekspresikan gen mamalia ID30448A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/209,920 US6136599A (en) 1998-12-10 1998-12-10 Human hybrid host cell for mammalian gene expression

Publications (1)

Publication Number Publication Date
ID30448A true ID30448A (id) 2001-12-06

Family

ID=22780882

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101235A ID30448A (id) 1998-12-10 1999-12-08 Sel induk hibrid manusia untuk mengekspresikan gen mamalia

Country Status (27)

Country Link
US (1) US6136599A (uk)
EP (1) EP1137768B1 (uk)
JP (3) JP4332300B2 (uk)
KR (1) KR100627753B1 (uk)
CN (1) CN1230532C (uk)
AT (1) ATE306547T1 (uk)
AU (1) AU757188B2 (uk)
BG (1) BG65263B1 (uk)
BR (1) BRPI9916095B8 (uk)
CA (1) CA2353698C (uk)
CU (2) CU23382A3 (uk)
CZ (1) CZ302677B6 (uk)
DE (1) DE69927707T2 (uk)
DK (1) DK1137768T3 (uk)
ES (1) ES2249929T3 (uk)
HU (1) HU229775B1 (uk)
ID (1) ID30448A (uk)
IL (2) IL143351A0 (uk)
NO (1) NO330548B1 (uk)
PL (1) PL205549B1 (uk)
RO (1) RO121563B1 (uk)
RU (1) RU2228355C2 (uk)
SI (1) SI20693B (uk)
SK (1) SK287888B6 (uk)
TR (1) TR200101642T2 (uk)
UA (1) UA77642C2 (uk)
WO (1) WO2000034462A1 (uk)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136599A (en) * 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression
US6358703B1 (en) 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
US6348192B1 (en) * 1999-05-11 2002-02-19 Bayer Corporation Interleukin-2 mutein expressed from mammalian cells
US20040235715A1 (en) * 1999-11-12 2004-11-25 Bayer Corporation Method of producing glycosylated bikunin
US7094587B2 (en) * 2000-06-27 2006-08-22 Millennium Pharmaceuticals, Inc. 16002 Molecules and uses therefor
US6569657B1 (en) * 2000-06-27 2003-05-27 Millennium Pharmaceuticals, Inc. 32140, a novel human aldehyde dehydrogenase and uses therefor
MY139948A (en) * 2000-09-28 2009-11-30 Bayer Corp Enhanced transfection system
US7723102B2 (en) * 2000-09-28 2010-05-25 Bayer Corporation Enhanced transfection system
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
KR100496861B1 (ko) 2002-09-26 2005-06-22 삼성전자주식회사 하나의 핸들러에 2개 이상의 테스트 보드를 갖는 테스트장비 및 그 테스트 방법
DE60333228D1 (de) 2002-12-02 2010-08-12 Amgen Fremont Inc Gegen den tumor nekrose faktor gerichtete antikörper und deren verwendungen
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
SI3130601T1 (sl) 2004-11-12 2020-11-30 Bayer Healthcare Llc Usmerjena modifikacija FVIII
BRPI0812398A2 (pt) 2007-06-06 2019-09-24 Domantis Ltd domínio variável simples de imunoglobulina anti-vegf, antagonista anti-vegf, domínio variável simples de imunoglobulina resistente à protease, uso do antagonista vegf, método para a dispensação oral ou dispensação de um medicamento ao trato gi de um paciente ou ao pulmão ou tecido pulmonar ou olho de um paciente, dispositivo de dispensação pulmonar, formulação oral, ligando específico duplo, ácido nucleico isolado ou recombinante, vetor, célula hospedeira, método para produzir polipeptídeo, composição farmacêutica, polipeptídeo, e, proteína de fusão
WO2009126564A1 (en) 2008-04-07 2009-10-15 Bayer Healthcare Llc Methods of recombinant production of glycoproteins
KR101005967B1 (ko) 2008-04-12 2011-01-05 (주)셀트리온 우수한 재조합 단백질을 생산하기 위한 인간 숙주 세포
US9090948B2 (en) * 2008-09-30 2015-07-28 Abbott Molecular Inc. Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
US8778677B2 (en) * 2009-06-10 2014-07-15 BTS Research International PTY. Ltd. Methods of generating hybrid/chimeric cells, and uses thereof
EP3487998B1 (en) 2016-07-19 2023-07-12 Brandeis University Compositions and methods for identifying rna binding polypeptide targets
WO2019219765A1 (en) 2018-05-16 2019-11-21 Morphosys Ag Antibodies targeting glycoprotein vi
MA55285A (fr) 2019-03-14 2022-01-19 Morphosys Ag Anticorps ciblant c5ar
KR102648479B1 (ko) * 2019-06-10 2024-03-15 초 플러스 인크. 단백질 기반 의약들 (protein-based pharmaceuticals) 의 고 수준 생산을 위한 세포주들 (cell lines)
US20230357398A1 (en) 2020-09-24 2023-11-09 Morphosys Ag Novel human antibodies binding to human cd3 epsilon
CN113604425B (zh) * 2021-06-22 2022-10-18 中山康天晟合生物技术有限公司 一种适应无血清培养基环境的wayne293 lvpro细胞及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US6136599A (en) * 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression

Also Published As

Publication number Publication date
CA2353698A1 (en) 2000-06-15
JP4332300B2 (ja) 2009-09-16
JP2009148295A (ja) 2009-07-09
NO20012806D0 (no) 2001-06-07
US6136599A (en) 2000-10-24
NO330548B1 (no) 2011-05-16
AU1938300A (en) 2000-06-26
EP1137768A4 (en) 2002-09-18
IL143351A0 (en) 2002-04-21
CN1339063A (zh) 2002-03-06
WO2000034462A1 (en) 2000-06-15
CZ20012023A3 (cs) 2001-10-17
UA77642C2 (en) 2007-01-15
CA2353698C (en) 2012-02-21
DE69927707T2 (de) 2006-07-13
BG65263B1 (bg) 2007-10-31
JP2002531125A (ja) 2002-09-24
SK287888B6 (sk) 2012-03-02
EP1137768B1 (en) 2005-10-12
CU23238A1 (es) 2007-09-26
ES2249929T3 (es) 2006-04-01
SK7912001A3 (en) 2002-03-05
JP2014131513A (ja) 2014-07-17
ATE306547T1 (de) 2005-10-15
JP5508740B2 (ja) 2014-06-04
HU229775B1 (en) 2014-07-28
BRPI9916095B8 (pt) 2021-05-25
JP5826311B2 (ja) 2015-12-02
NO20012806L (no) 2001-06-07
KR20020002360A (ko) 2002-01-09
CU23382A3 (es) 2009-06-25
BR9916095A (pt) 2001-09-04
EP1137768A1 (en) 2001-10-04
RU2228355C2 (ru) 2004-05-10
SI20693B (sl) 2008-12-31
KR100627753B1 (ko) 2006-09-26
RO121563B1 (ro) 2007-11-30
TR200101642T2 (tr) 2001-11-21
HUP0104681A2 (hu) 2002-04-29
HUP0104681A3 (en) 2005-10-28
BG105566A (en) 2002-03-29
IL143351A (en) 2009-12-24
DK1137768T3 (da) 2005-12-19
BRPI9916095B1 (pt) 2015-10-13
CZ302677B6 (cs) 2011-08-31
CN1230532C (zh) 2005-12-07
AU757188B2 (en) 2003-02-06
SI20693A (sl) 2002-04-30
DE69927707D1 (de) 2006-02-23
PL205549B1 (pl) 2010-04-30

Similar Documents

Publication Publication Date Title
ID30448A (id) Sel induk hibrid manusia untuk mengekspresikan gen mamalia
Tjian et al. Biological activity of purified simian virus 40 T antigen proteins.
Manuri et al. piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies
RU2003131342A (ru) Способы культивирования цирковирусов
KR20120038531A (ko) 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법
EP1100878B8 (de) Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen
AP1678A (en) Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
JP2021512618A (ja) 閉鎖系におけるｃａｒ−ｔ細胞の製造方法
Macdonald Development of new cell lines for animal cell biotechnology
JPH04228066A (ja) 外来遺伝子発現用培養細胞
CN104342454A (zh) 用于用动物细胞大量生产源自外源基因的蛋白质的表达载体及其应用
NZ512235A (en) Human hybrid host cell for mammalian gene expression
DK0870044T3 (da) Reguleret proteinekspression i stabilt transfekterede pattedyrsceller
Graessmann et al. Fused cells are suited for microinjection
JP2500384B2 (ja) 生理活性物質の製造法
Stein et al. Acidic nuclear protein synthesis in Rous sarcoma virus infected chick embryo fibroblasts
Bayley et al. Immortalization of rat keratinocytes by transfection with polyomavirus large T gene
Waldman et al. Transfer of herpes simplex virus thymidine kinase synthesized in bacteria by a high-expression plasmid to tissue culture cells by protoplast fusion
JPH0732705B2 (ja) 動物細胞増殖用組成物およびそれを用いる動物細胞の増殖方法
Al et al. Optimization of Human Antibody Production by Xenohybridization of EBV-Transformed Cell Lines
AU666800B2 (en) Process for producing exogenous protein
JPH0561907B2 (uk)
Thompson Developments in Biological Standardisation. Volume 72: Progress in Animal Retroviruses: Editors, D. Gaudry and W. Hennessen, Karger, Basel, Switzerland, 1990, ISBN 3-8055-5271-8,£ 91.30
Hacker Recombinant Protein Expression in Mammalian Cells